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Association between MLXIPL, BUD13 and ZNF259 gene polymorphisms and
serum lipid levels in the Mulao and Han populations
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Hospital, Guangxi Medical University, Nanning 530021, China
Objectives: The association of single nucleotide polymorphisms (SNPs) in the MLX
interacting protein-like (MLXIPL), BUD13 homolog (BUD13) and zinc ﬁnger protein
259 (ZNF259) genes is inconsistent in diverse racial/ethnic groups. The present study
was undertaken to detect the association of the MLXIPL (rs35332062 A358V,
rs3812316 Q241H, rs13235543 P342P and rs799161 g.11092833T>C), BUD13
(rs10790162 +1741T>C, rs17119975 -575A>G and rs11556024 *147C>T) and
ZNF259 (rs2075290 -336G>A and rs964184 +359C>G) SNPs and serum lipid levels
in the Guangxi Mulao and Han populations.
Methods: A total of 825 subjects of Mulao and 781 participants of Han Chinese were
randomly selected fromour previous stratiﬁed randomizedsamples.Genotypingof9SNPs
was performed by polymerase chain reaction and restriction fragment length poly-
morphism combined with gel electrophoresis, and then conﬁrmed by direct sequencing.
Results: The genotype and allele frequencies of ZNF259 rs2075290 and rs964184 and
BUD13 rs10790162 were different between the Mulao and Han populations
(P<0.001). The SNPs of ZNF259 rs2075290 and rs964184, BUD13 rs10790162, and
MLXIPL rs3812316 and rs13235543 were associated with serum triglyceride (TG);
ZNF259 rs2075290 and BUD13 rs10790162 with total cholesterol; and MLXIPL
rs35332062 with apolipoprotein (Apo) A1 in the Mulao population (P<0.006). The
SNPs of ZNF259 rs2075290 and BUD13 rs10790162 were associated with serum TG,
and ZNF259 rs2075290 with ApoA1/ApoB ratio in the Han population (P<0.006).
Signiﬁcant linkage disequilibrium was noted between ZNF259 rs2075290 and
rs964184, ZNF259 rs2075290 and BUD13 rs10790162, ZNF259 rs964184 and
BUD13 rs10790162, and MLXIPL rs3812316 and rs13235543 (r2>0.50, P<0.001).
Six haplotypes (among 5 SNPs of BUD13/ZNF259) and 7 haplotypes (among 4 SNPs
of MLXIPL) with a frequency>1% were identiﬁed in the Mulao and Han populations.
We combined 17 haplotypes (among 5 SNPs of BUD13/ZNF259) and 13 haplotypes
(among 4 SNPs of MLXIPL) with frequencies less than 3% into one group, called
“rare_hap”. The A-C-G-A-C (among the ZNF259 rs2075290 and rs964184, and
BUD13 rs10790162, rs17119975 and rs11556024 SNPs) and C-C-C-C (among the
MLXIPL rs799161, rs35332062, rs3812316 and rs13235543 SNPs) haplotypes
accounted for over half of the % haplotype of each ethnic group. Signiﬁcant differ-
ences in the frequencies of the A-C-G-A-C and G-G-A-A-C haplotypes between the
two ethnic groups were observed (P<0.01 for each).
Conclusions: The present study shows that several SNPs in the MLXIPL, BUD13 and
ZNF259 are associated with serum lipid parameters in the Guangxi Mulao and Han
populations. But the association is different between the two ethnic groups. There may
be an ethnic speciﬁc association of these SNPs and serum lipid parameters.
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of short-term simvastatin and atorvastatin therapy with different dosages in
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Objectives: We investigated the lipid-lowing efﬁcacy of short-term simvastatin and
atorvastatin therapy with different dosages of routine clinical practice, and studied the
association of plasma concentrations, lipid-lowing efﬁcacy and safety of simvastatin
and atorvastatin in Chinese population.
Methods: 200 in-hospital patients with hypercholesterolemia were enrolled in the
randomized controlled study. The patients were treated with daily doses of 20mg
simvastatin, 40mg simvastatin, 10mg atorvastatin or 20mg atorvastatin orally each
evening. The lipid proﬁles before and after 1-week treatment, as well as the plasma
concentrations in the morning after 1-week treatment, which was 8 hours after last
administration of simvastatin or atorvastatin, were assessed. All adverse events of
simvastatin and atorvastatin were also recorded.
Results: Simvastatin and atorvastatin at each dose all effectively reduced TC and
LDL-c levels from baseline to week 1 (P<0.001). Simvastatin 20mg and simvastatin
40mg produced 17.5% and 24.6% reduction in LDL-c, respectively, and atorvastatin
10mg and atorvastatin 20mg produced 19.8% and 21.3% reduction in LDL-c,
respectively. However, No differences were seen between different doses of simva-
statin or atorvastatin. More patients at high risk in the study and in the 20mg ator-
vastatin group reached LDL-c target than those at very high risk (71% versus 32.8%,
P<0.001 for the overall patients; 80% versus 35.7%, P<0.05 for 20mg atorvastain
group). There was no signiﬁcant difference in the plasma concentrations between
different dosages of simvastatin and atorvastatin. The plasma concentrations in 10mg
atorvastatin group were correlated with the percent reduction of LDL-c (P<0.05). No
relationship was seen between the plasma concentrations and adverse events of
simvastatin and atorvastatin.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/EConclusions: Simvastatin and atorvastatin at different doses used by routine clinical
practice can effectively reduce the TC and LDL-c levels after short-term treatment.
Only the association between plasma concentration and lipid-lowering efﬁcacy was
seen in atrovastatin 10mg group. No association was observed between the plasma
concentrations, efﬁcacy and adverse events of simvastatin and atorvastatin in other
groups.
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Contributing Factors of Weight Regain after Weight Loss in Ahvaz, Iran
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Objectives: Obesity is one of modiﬁable risk factors of cardiovascular diseases.
Weight regain (WR) is very common among patients who lose weight. Physiological,
psychological and behavioral factors are known to cause WR. Identifying the factors
associated with WR in different populations is important. This study was carried out to
identify the contributing factors of WR in Ahvaz, Iran.
Methods: In this case-control study, from clients referred to dietetics ofﬁces in Ahvaz,
Iran from 2009 onwards, those older than 18 years and with no history of serious
diseases such as cardiovascular diseases, diabetes mellitus, liver or kidney diseases
and cancer were recruited. Overall 8000 ﬁles were investigated. All eligible clients
who had lost at least 10 percent of initial weight and at least 6 months after their last
appointments were invited to participate in this study. Weight maintainers (WM) were
clients who had maintained their latest recorded weight or lower. WR was deﬁned as
regaining of at least 10 percent of the latest recorded weight. Seventy nine persons in
the WR group were compared with 73 in WM group. Information about weight, age,
sex, physical activities, breakfast consumption, speciﬁc changes in living conditions
(e.g. divorce or death of relatives), hunger and overeating were collected from the ﬁle
and by interview. Stress and depression were evaluated by DASS-21 questionnaire.
Appropriate statistical tests, including Chi square and logistic regression were used for
data analyses.
Results: Signiﬁcant contributing factors of WR were inactive life style (less than 5 minutes
walking per day and lack of regular exercise), depression or stress, inappropriate strategies
(overeating) in confronting usual life problems, skipping breakfast, unrestraint eating, not to eat
regular meals, and excessive hunger. According to multivariate logistic regression test, the sig-
niﬁcant predicting variables ofWRwere irregular consumption ofmeals and excessive hunger.
Conclusions: To prevent weight regain, diet therapy should be accompanied by
behavioral, physical activity and psychological modiﬁcations.
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Objectives: To investigate serum lipid proﬁles in different age-related segments in
women in Shijiazhuang and to evaluate the relationship between the serum lipids and
body mass index (BMI), waist circumference (WC), and waist-hip ratio (WHR).
Methods: 1992 women were recruited in this study. Body height, body mass, body
mass index (BMI), waist circumference (WC), hip circumference, waist-hip ratio
(WHR) and serum lipid levels were measured in the morning after an overnight fast.
Results: The rate of dyslipidemia was increasing with the growing of age. The
detection rates of high TC, high LDL-C, high TG and low HDL-C were 36.38%,
25.07%, 40.52% and 5.53%, respectively. There was no signiﬁcant difference in lipid
levels between age-related segments (P>0.05). The levels of TC, TG and LDL-C
increased with the growing of BMI. The levels of TC, TG and LDL-C were signiﬁ-
cantly higher in group of obesity than in group of normal BMI (TC: 5.780.96 mmol/
L vs 5.320.91 mmol/L, P<0.05; TG: 1.980.59 mmol/L vs 1.170.38 mmol/L,
P<0.05; LDL-C: 3.270.44 mmol/L vs 2.860.57 mmol/L, P<0.05). The level of
TG was signiﬁcantly higher in population with abnormal WC and WHR than in
population with normal WC and WHR (P<0.05).
Conclusions: The rate of dyslipidemia was associated with age in women in Shi-
jiazhuang. The levels of TC, TG and LDL-C was positively correlated with BMI. The
level of TG was positively correlated with WC and WHR.
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Evaluation of apo A I, apo B, apo A I / apo B in the diagnosis of coronary
heart disease
Liu Ying
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Objectives: Whether the apo A I, apo B, apo I /apo B is relevant to the coronary
atherosclerosis heart disease and Coronary artery lesion severity by statistical analysis,
and the three level Coronary is evaluated how close to stenosis disease.
Methods: In January to March 2013, a total of 512 patients underwent coronary
angiography according to the results of coronary angiography were divided into A, B,pidemiology, Prevention and Control C107
